Fukang (Shanghai) Health Technology
Researcher and developer of innovative drugs focused on oncology treatments.
Launch date
Market cap
-
Enterprise valuation
AUD85—128m (Dealroom.co estimates Jan 2024.)
Shanghai China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY100m | Series C | |
| Total Funding | AUD21.3m | ||